Rockleo , great post ..
And very curious , more studies for dr Fauci approved by FDA as Adaptive Design Studies , when they may “PICK” at the results during active study , and choose endpoints depending what they see .
Remdesivir ,
Lenzilumab and now all those ..
FDA approving all this type of study as we see ONLY for Dr Fauci designed studies and Dr Fauci favorites ..
How no one in NIH , FDA see anything wrong with that .
All imo